Mergers & Acquisitions - USA, Neurological

Filter

Current filters:

USANeurological

Popular Filters

NovaDel sells ZolpiMist NDA, license and IP to Amherst Pharma

23-09-2014

NovaDel Pharma has sold its insomnia drug ZolpiMist (zolpidem oral spray) New Drug Application to fellow…

Amherst PharmaceuticalsMergers & AcquisitionsNeurologicalNovaDel PharmaPharmaceuticalUSAZolpiMist

Eisai divests US Zonegran rights to Concordia

Eisai divests US Zonegran rights to Concordia

07-09-2014

Japanese drugmaker Eisai (TYO: 4523) says its US subsidiary has entered into an agreement to divest its…

BiotechnologyConcordia PharmaceuticalsEisaiMergers & AcquisitionsNeurologicalUSAZonegran

Shire finally accepts AbbVie’s takeover offer

Shire finally accepts AbbVie’s takeover offer

18-07-2014

After a protracted and at times hostile courtship, Ireland-headquartered drugmaker Shire has finally…

AbbVieHumiraMergers & AcquisitionsNeurologicalPharmaceuticalRare diseasesShireUSA

Shire confirms it has entered into talks with AbbVie

Shire confirms it has entered into talks with AbbVie

12-07-2014

Following reports by the Bloomberg news service, on Friday Ireland-based drugmaker Shire confirmed that…

AbbVieIrelandMergers & AcquisitionsNeurologicalPharmaceuticalRare diseasesShireUSA

Back to top